Stephen P. Robertson serves as Executive at Aurinia Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Stephen P. Robertson has executed 8 insider transactions totaling $683.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 20, 2026 involved selling 34,638 shares valued at $498.8K.
Stephen P. Robertson currently holds 483,296 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen P. Robertson has been a net seller of AUPH stock. They have purchased $14.5K and sold $669.3K worth of shares.
Stephen P. Robertson's most recent insider trade was on Feb 20, 2026, when they sold 34,638 shares at $14.40 per share.
Get notified when new Form 4 filings are submitted
| $5.60 |
| Discretionary |
| Feb 20, 2024 | AUPH | $0 | Award | 194,230 | $N/A | Discretionary |
| Mar 2, 2023 | AUPH | $172.5K | Sale | 19,644 | $8.78 | Discretionary |
| Mar 2, 2023 | AUPH | $173.5K | Sale | 19,402 | $8.94 | Discretionary |
| Mar 2, 2023 | AUPH | $0 | Award | 204,810 | $N/A | Discretionary |
| Mar 2, 2022 | AUPH | $0 | Award | 8,500 | $N/A | Discretionary |
| Jan 28, 2021 | AUPH | $14.5K | Purchase | 900 | $16.14 | Discretionary |